Rock Springs Capital Management as of Sept. 30, 2021
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 153 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Agilon Health (AGL) | 3.9 | $185M | 7.1M | 26.21 | |
Humana (HUM) | 2.8 | $133M | 342k | 389.15 | |
Align Technology (ALGN) | 2.8 | $133M | 200k | 665.43 | |
Insulet Corporation (PODD) | 2.6 | $124M | 438k | 284.23 | |
Intuitive Surgical Com New (ISRG) | 2.5 | $119M | 120k | 994.15 | |
Agios Pharmaceuticals (AGIO) | 2.5 | $118M | 2.6M | 46.15 | |
Zai Lab Adr (ZLAB) | 2.4 | $114M | 1.1M | 105.39 | |
IDEXX Laboratories (IDXX) | 2.4 | $112M | 180k | 621.90 | |
Hca Holdings (HCA) | 2.3 | $109M | 450k | 242.72 | |
Neurocrine Biosciences (NBIX) | 2.1 | $101M | 1.1M | 95.91 | |
Argenx Se Sponsored Adr (ARGX) | 2.0 | $95M | 315k | 302.00 | |
Novavax Com New (NVAX) | 2.0 | $94M | 455k | 207.31 | |
UnitedHealth (UNH) | 2.0 | $94M | 240k | 390.74 | |
Immunocore Hldgs Ads (IMCR) | 1.9 | $91M | 2.4M | 37.07 | |
Blueprint Medicines (BPMC) | 1.8 | $87M | 850k | 102.81 | |
Horizon Therapeutics Pub L SHS | 1.6 | $77M | 702k | 109.54 | |
Freshpet (FRPT) | 1.6 | $75M | 527k | 142.69 | |
Invitae (NVTAQ) | 1.6 | $74M | 2.6M | 28.43 | |
Nevro (NVRO) | 1.6 | $74M | 636k | 116.38 | |
Ultragenyx Pharmaceutical (RARE) | 1.5 | $72M | 801k | 90.19 | |
Aclaris Therapeutics (ACRS) | 1.4 | $69M | 3.8M | 18.00 | |
Edwards Lifesciences (EW) | 1.4 | $66M | 582k | 113.21 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.3 | $64M | 400k | 159.39 | |
Mirati Therapeutics | 1.3 | $63M | 354k | 176.91 | |
Phreesia (PHR) | 1.3 | $60M | 970k | 61.70 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $59M | 311k | 188.81 | |
Evolent Health Cl A (EVH) | 1.2 | $58M | 1.9M | 31.00 | |
Pacira Pharmaceuticals (PCRX) | 1.2 | $56M | 1.0M | 56.00 | |
EXACT Sciences Corporation (EXAS) | 1.1 | $54M | 570k | 95.45 | |
Prothena Corp SHS (PRTA) | 1.1 | $51M | 710k | 71.23 | |
Teleflex Incorporated (TFX) | 1.0 | $49M | 130k | 376.55 | |
Karuna Therapeutics Ord | 1.0 | $48M | 392k | 122.33 | |
Arvinas Ord (ARVN) | 1.0 | $48M | 578k | 82.18 | |
Cerevel Therapeutics Hldng I (CERE) | 1.0 | $47M | 1.6M | 29.50 | |
Shockwave Med | 1.0 | $45M | 220k | 205.88 | |
Acadia Healthcare (ACHC) | 1.0 | $45M | 710k | 63.78 | |
Verve Therapeutics (VERV) | 1.0 | $45M | 963k | 47.00 | |
Kymera Therapeutics (KYMR) | 0.9 | $43M | 733k | 58.74 | |
Health Catalyst (HCAT) | 0.9 | $43M | 850k | 50.01 | |
Seagen | 0.9 | $43M | 250k | 169.80 | |
Penumbra (PEN) | 0.8 | $39M | 148k | 266.50 | |
Accolade (ACCD) | 0.8 | $39M | 923k | 42.17 | |
Encompass Health Corp (EHC) | 0.8 | $38M | 500k | 75.04 | |
Travere Therapeutics (TVTX) | 0.8 | $36M | 1.5M | 24.25 | |
Baxter International (BAX) | 0.8 | $36M | 450k | 80.43 | |
Warby Parker Cl A Com (WRBY) | 0.7 | $35M | 650k | 53.05 | |
Graphite Bio | 0.7 | $34M | 2.1M | 16.39 | |
Intersect Ent | 0.7 | $33M | 1.2M | 27.20 | |
Sarepta Therapeutics (SRPT) | 0.7 | $32M | 350k | 92.48 | |
Allakos (ALLK) | 0.7 | $32M | 306k | 105.87 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $30M | 1.5M | 19.92 | |
Covetrus | 0.6 | $29M | 1.6M | 18.14 | |
Immuneering Corp Class A Com (IMRX) | 0.6 | $29M | 1.1M | 26.55 | |
Sierra Oncology Com New | 0.6 | $29M | 1.3M | 21.92 | |
Mersana Therapeutics (MRSN) | 0.6 | $29M | 3.0M | 9.43 | |
Cytokinetics Note 4.000%11/1 (Principal) | 0.6 | $28M | 8.0M | 3.54 | |
Dynavax Technologies Corp Com New (DVAX) | 0.6 | $28M | 1.4M | 19.21 | |
Atea Pharmaceuticals (AVIR) | 0.6 | $26M | 750k | 35.06 | |
Irhythm Technologies (IRTC) | 0.6 | $26M | 448k | 58.56 | |
Dex (DXCM) | 0.5 | $25M | 47k | 546.86 | |
Pulmonx Corp (LUNG) | 0.5 | $25M | 700k | 35.98 | |
Guardant Health (GH) | 0.5 | $25M | 200k | 125.01 | |
Lifestance Health Group (LFST) | 0.5 | $25M | 1.7M | 14.50 | |
Cullinan Oncology (CGEM) | 0.5 | $24M | 1.1M | 22.57 | |
Acumen Pharmaceuticals (ABOS) | 0.5 | $24M | 1.6M | 14.86 | |
Abcam Ads | 0.5 | $23M | 1.1M | 20.27 | |
Aadi Bioscience (AADI) | 0.5 | $23M | 765k | 29.37 | |
Amarin Corp Spons Adr New (AMRN) | 0.5 | $22M | 4.3M | 5.10 | |
Icosavax | 0.5 | $22M | 734k | 29.59 | |
CONMED Corporation (CNMD) | 0.4 | $21M | 163k | 130.83 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $21M | 263k | 79.79 | |
Bolt Biotherapeutics (BOLT) | 0.4 | $21M | 1.6M | 12.65 | |
Novocure Ord Shs (NVCR) | 0.4 | $20M | 175k | 116.17 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $20M | 254k | 77.29 | |
Oak Street Health | 0.4 | $19M | 441k | 42.53 | |
Epizyme | 0.4 | $18M | 3.6M | 5.12 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $18M | 900k | 19.74 | |
Rigel Pharmaceuticals Com New | 0.4 | $17M | 4.8M | 3.63 | |
Spero Therapeutics (SPRO) | 0.4 | $17M | 942k | 18.41 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.3 | $16M | 16M | 1.04 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $16M | 315k | 50.56 | |
Amryt Pharma Sponsored Ads | 0.3 | $16M | 1.3M | 12.04 | |
Kura Oncology (KURA) | 0.3 | $15M | 823k | 18.73 | |
Relay Therapeutics (RLAY) | 0.3 | $15M | 470k | 31.53 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $15M | 536k | 27.12 | |
Prometheus Biosciences | 0.3 | $15M | 610k | 23.71 | |
Bright Health Group | 0.3 | $14M | 1.8M | 8.16 | |
Leap Therapeutics | 0.3 | $14M | 3.5M | 4.01 | |
Nkarta (NKTX) | 0.3 | $14M | 503k | 27.81 | |
Biomea Fusion (BMEA) | 0.3 | $14M | 1.2M | 11.97 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $14M | 613k | 22.13 | |
Macrogenics (MGNX) | 0.3 | $13M | 642k | 20.94 | |
Vincerx Pharma Com New (VINC) | 0.3 | $13M | 800k | 16.17 | |
Fulcrum Therapeutics (FULC) | 0.3 | $13M | 455k | 28.21 | |
West Pharmaceutical Services (WST) | 0.3 | $13M | 30k | 424.53 | |
Akero Therapeutics (AKRO) | 0.3 | $13M | 569k | 22.35 | |
Aeglea Biotherapeutics | 0.3 | $13M | 1.6M | 7.95 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $12M | 505k | 24.25 | |
Rocket Pharmaceuticals (RCKT) | 0.3 | $12M | 403k | 29.89 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $12M | 4.8M | 2.42 | |
Applied Therapeutics (APLT) | 0.2 | $12M | 702k | 16.60 | |
Prelude Therapeutics (PRLD) | 0.2 | $11M | 362k | 31.25 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $11M | 2.2M | 5.17 | |
Trillium Therapeutics Com New | 0.2 | $11M | 629k | 17.56 | |
Orion Acquisition Corp Unit 02/19/2026 | 0.2 | $9.9M | 1.0M | 9.89 | |
Inozyme Pharma (INZY) | 0.2 | $9.9M | 850k | 11.59 | |
Spruce Biosciences (SPRB) | 0.2 | $9.7M | 1.6M | 6.01 | |
Amicus Therapeutics (FOLD) | 0.2 | $9.7M | 1.0M | 9.55 | |
Nurix Therapeutics (NRIX) | 0.2 | $9.5M | 319k | 29.96 | |
Day One Biopharmaceuticals I (DAWN) | 0.2 | $8.9M | 376k | 23.73 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $8.9M | 583k | 15.28 | |
Chinook Therapeutics | 0.2 | $8.8M | 688k | 12.76 | |
Reneo Pharmaceuticals (RPHM) | 0.2 | $8.5M | 1.1M | 7.45 | |
Gamida Cell SHS | 0.2 | $8.4M | 2.1M | 3.92 | |
Paratek Pharmaceuticals | 0.2 | $8.1M | 1.7M | 4.86 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $8.0M | 612k | 13.06 | |
F-star Therapeutics | 0.2 | $7.7M | 1.1M | 7.32 | |
Kinnate Biopharma | 0.2 | $7.7M | 333k | 23.02 | |
Compugen Ord (CGEN) | 0.2 | $7.7M | 1.3M | 5.97 | |
Fusion Pharmaceuticals | 0.2 | $7.5M | 948k | 7.92 | |
Eargo | 0.1 | $6.6M | 975k | 6.73 | |
Fate Therapeutics (FATE) | 0.1 | $6.5M | 110k | 59.27 | |
Shattuck Labs (STTK) | 0.1 | $6.4M | 314k | 20.38 | |
Phasebio Pharmaceuticals | 0.1 | $5.7M | 1.8M | 3.11 | |
Athira Pharma (ATHA) | 0.1 | $5.2M | 552k | 9.38 | |
Theravance Biopharma (TBPH) | 0.1 | $5.1M | 688k | 7.40 | |
Design Therapeutics (DSGN) | 0.1 | $4.9M | 334k | 14.69 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.1 | $4.9M | 761k | 6.38 | |
Atai Life Sciences Nv SHS (ATAI) | 0.1 | $4.7M | 318k | 14.79 | |
Galera Therapeutics (GRTX) | 0.1 | $4.6M | 568k | 8.10 | |
Tempest Therapeutics (TPST) | 0.1 | $4.5M | 310k | 14.47 | |
Essa Pharma Com New (EPIX) | 0.1 | $4.1M | 508k | 8.00 | |
Acelrx Pharmaceuticals | 0.1 | $3.9M | 3.8M | 1.02 | |
Innovage Hldg Corp (INNV) | 0.1 | $3.5M | 525k | 6.61 | |
Imara | 0.1 | $3.4M | 829k | 4.08 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $3.3M | 3.3M | 1.01 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.1M | 309k | 9.96 | |
Atreca Cl A Com (BCEL) | 0.1 | $2.9M | 460k | 6.23 | |
Nuvation Bio Com Cl A (NUVB) | 0.0 | $2.4M | 237k | 9.94 | |
Poseida Therapeutics I (PSTX) | 0.0 | $2.1M | 290k | 7.29 | |
Fs Development Corp Ii Com Cl A | 0.0 | $2.1M | 209k | 9.95 | |
Eucrates Biomedical Acqu Cor Unit 10/23/2027 | 0.0 | $2.1M | 206k | 9.95 | |
Turmeric Acquisition Corp Unit 10/08/2025 | 0.0 | $2.0M | 206k | 9.93 | |
Population Health Invs Co In Unit 99/99/9999 | 0.0 | $2.0M | 201k | 10.00 | |
Jiya Acquisition Corp Com Cl A | 0.0 | $2.0M | 206k | 9.75 | |
Helix Acquisition Corp Com Cl A | 0.0 | $1.5M | 155k | 9.95 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.93 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.91 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.34 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.0M | 1.0M | 1.04 | |
Apellis Pharmaceuticals (APLS) | 0.0 | $872k | 27k | 32.96 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $675k | 500k | 1.35 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $343k | 134k | 2.56 |